Pharma-Bio Serv, Inc.
PBSV · OTCMCIK 1304161fmd_0KG119PVGQ9HWBN5WVDWD9PAN7Services · Services-Management Consulting ServicesTemplate: Standard
Coverage: Nov 01, 2009 to Jul 31, 2026, 65 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | – | 13 | 18 | 20 | 22 | 20 | 19 | 17 | 10 | 9 |
| Cost of revenue | 14 | 9 | 12 | 13 | 15 | 15 | 15 | 12 | 7 | 6 |
| Gross profit | 6 | 4 | 6 | 6 | 7 | 5 | 5 | 5 | 3 | 3 |
| Selling, general and administrative | 6 | 5 | 5 | 4 | 4 | 9 | 4 | 4 | 4 | 4 |
| Operating income | (0) | (1) | (1) | 2 | 2 | (4) | 1 | 1 | (1) | (1) |
| Interest expense | – | – | – | – | – | – | – | – | – | – |
| Interest and investment income | – | – | – | – | – | – | 0 | 0 | 0 | 0 |
| Other non-operating income (expense) | (0) | 0 | 0 | 1 | 0 | 2 | 0 | 1 | 1 | 1 |
| Income before taxes | (0) | (1) | 2 | 2 | 2 | (2) | 1 | 2 | (1) | (0) |
| Income tax expense | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income from continuing operations | (0) | (1) | 1 | 2 | 2 | (2) | 1 | 1 | (1) | (1) |
| Net income | (0) | (1) | 1 | 2 | 2 | (2) | 1 | 1 | (1) | (0) |